Next, we sought to investigate whether PKM2 mediates the enhancive role of DPYSL2 in the malignant behavior of bladder cancer cells by silencing PKM2 expression in DPYSL2-overexpressing bladder cancer cells. This evidence concerns the gene PKM and urinary bladder carcinoma.